NO953321D0 - 2,3 cyklisk kondenserte 1,4-dihydropyridiner, fremgangsmåte for fremstilling derav og deres anvendelse som legemidler - Google Patents
2,3 cyklisk kondenserte 1,4-dihydropyridiner, fremgangsmåte for fremstilling derav og deres anvendelse som legemidlerInfo
- Publication number
- NO953321D0 NO953321D0 NO953321A NO953321A NO953321D0 NO 953321 D0 NO953321 D0 NO 953321D0 NO 953321 A NO953321 A NO 953321A NO 953321 A NO953321 A NO 953321A NO 953321 D0 NO953321 D0 NO 953321D0
- Authority
- NO
- Norway
- Prior art keywords
- dihydropyridines
- drugs
- preparation
- cyclic condensed
- condensed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4430092A DE4430092A1 (de) | 1994-08-25 | 1994-08-25 | 2,3-Cyclisch kondensierte 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
NO953321D0 true NO953321D0 (no) | 1995-08-24 |
NO953321L NO953321L (no) | 1996-02-26 |
Family
ID=6526497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO953321A NO953321L (no) | 1994-08-25 | 1995-08-24 | 2,3 cyklisk kondenserte 1,4-dihydropyridiner, fremgangsmåte for fremstilling derav og deres anvendelse som legemidler |
Country Status (15)
Country | Link |
---|---|
US (1) | US6121284A (no) |
EP (1) | EP0705830A1 (no) |
JP (1) | JPH0859622A (no) |
KR (1) | KR960007594A (no) |
CN (1) | CN1127250A (no) |
AU (1) | AU3011095A (no) |
CA (1) | CA2156672A1 (no) |
CZ (1) | CZ217495A3 (no) |
DE (1) | DE4430092A1 (no) |
FI (1) | FI953956A (no) |
HU (1) | HU218209B (no) |
IL (1) | IL115029A0 (no) |
NO (1) | NO953321L (no) |
PL (1) | PL310147A1 (no) |
SK (1) | SK104495A3 (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6593335B1 (en) | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
US6265417B1 (en) | 1997-12-18 | 2001-07-24 | Abbott Laboratories | Potassium channel openers |
EP1131322A2 (en) * | 1998-10-28 | 2001-09-12 | Abbott Laboratories | Dihydropyridine compounds and methods of use |
MXPA02008615A (es) * | 2000-03-03 | 2003-04-14 | Abbott Lab | Abridores de canales de potasio de dihidropirazolona triciclica y dihidroisoxazolona triciclica. |
US6538004B2 (en) | 2000-03-03 | 2003-03-25 | Abbott Laboratories | Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
US20050075359A1 (en) * | 2003-03-14 | 2005-04-07 | Rikako Kono | Large conductance calcium-activated K channel opener |
AU2004272078A1 (en) * | 2003-09-10 | 2005-03-24 | Synta Pharmaceuticals Corp. | Dihydropyridine compounds for treating or preventing metabolic disorders |
US8916550B2 (en) * | 2005-05-09 | 2014-12-23 | Hydra Biosciences, Inc. | Compounds for modulating TRPV3 function |
WO2006122156A2 (en) * | 2005-05-09 | 2006-11-16 | Hydra Biosciences, Inc. | Compounds for modulating trpv3 function |
US9012217B2 (en) * | 2008-09-17 | 2015-04-21 | Burnham Institute For Medical Research | Benzimidazole compounds differentiate a mammalian stem cell into mesodermal or cardiomyocyte cells |
US9233926B2 (en) * | 2008-09-17 | 2016-01-12 | Sanford-Burnham Medical Research Institute | Compounds for stem cell differentiation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2003148A1 (de) | 1970-01-24 | 1971-07-29 | Bayer Ag | Neue 1,4-Dihydropyridinderivate |
US4021434A (en) * | 1972-01-22 | 1977-05-03 | Yamanouchi Pharmaceutical Co., Ltd. | Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate |
GB1430961A (en) | 1972-01-22 | 1976-04-07 | Yamanouchi Pharma Co Ltd | 1-substituted-1,4-dihyddrypyridine derivatives |
DE3410645A1 (de) * | 1984-03-23 | 1985-09-26 | Bayer Ag, 5090 Leverkusen | L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
DE3443678A1 (de) * | 1984-11-30 | 1986-06-05 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von 4-acyloxy-3-oxo-buttersaeureestern |
DE3521761A1 (de) * | 1985-06-19 | 1987-01-02 | Bayer Ag | Neue 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln |
DE3629545A1 (de) * | 1986-08-30 | 1988-03-10 | Bayer Ag | Dihydropyridinverbindungen, verfahren zu ihrer herstellung und ihre verwendung |
DE4125271A1 (de) * | 1991-07-31 | 1993-02-11 | Bayer Ag | Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester |
-
1994
- 1994-08-25 DE DE4430092A patent/DE4430092A1/de not_active Withdrawn
-
1995
- 1995-08-14 EP EP95112764A patent/EP0705830A1/de not_active Withdrawn
- 1995-08-17 AU AU30110/95A patent/AU3011095A/en not_active Abandoned
- 1995-08-18 JP JP7234704A patent/JPH0859622A/ja active Pending
- 1995-08-18 US US08/516,804 patent/US6121284A/en not_active Expired - Fee Related
- 1995-08-22 IL IL11502995A patent/IL115029A0/xx unknown
- 1995-08-22 CA CA002156672A patent/CA2156672A1/en not_active Abandoned
- 1995-08-23 PL PL95310147A patent/PL310147A1/xx unknown
- 1995-08-23 FI FI953956A patent/FI953956A/fi unknown
- 1995-08-24 SK SK1044-95A patent/SK104495A3/sk unknown
- 1995-08-24 CZ CZ952174A patent/CZ217495A3/cs unknown
- 1995-08-24 CN CN95116650A patent/CN1127250A/zh active Pending
- 1995-08-24 KR KR1019950026300A patent/KR960007594A/ko not_active Application Discontinuation
- 1995-08-24 NO NO953321A patent/NO953321L/no unknown
- 1995-08-25 HU HU9502503A patent/HU218209B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HU218209B (hu) | 2000-06-28 |
CZ217495A3 (en) | 1996-03-13 |
HUT74615A (en) | 1997-01-28 |
IL115029A0 (en) | 1995-12-08 |
US6121284A (en) | 2000-09-19 |
FI953956A (fi) | 1996-02-26 |
DE4430092A1 (de) | 1996-02-29 |
PL310147A1 (en) | 1996-03-04 |
AU3011095A (en) | 1996-03-07 |
CA2156672A1 (en) | 1996-02-26 |
NO953321L (no) | 1996-02-26 |
EP0705830A1 (de) | 1996-04-10 |
HU9502503D0 (en) | 1995-10-30 |
FI953956A0 (fi) | 1995-08-23 |
KR960007594A (ko) | 1996-03-22 |
CN1127250A (zh) | 1996-07-24 |
SK104495A3 (en) | 1996-06-05 |
JPH0859622A (ja) | 1996-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO993519L (no) | Fenofibrat farmasöytisk blanding som har höy biotilgjengelighet og fremgangsmÕte for fremstilling av den | |
NO20000185L (no) | Kondenserte 1,2,4-tiadiazinderivater, deres fremstilling og anvendelse | |
DK300287A (da) | Kondenserede cycliske azepin-2-oner, og deres anvendelse som antihypertensive laegemidler | |
NO20005146D0 (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
NO871052L (no) | 1,1-disubstituerte cyklopropanderivater, fremgangsmaate til deres fremstilling og deres anvendelse. | |
FI900870A0 (fi) | Foerfarande foer belaeggning av papper med kompositioner, som innehaoller mikrokapslar. | |
DK0903339T3 (da) | Biphenylsulfonylcyanamid, fremgangsmåde til deres fremstilling og deres anvendelse som medikament | |
NO953321D0 (no) | 2,3 cyklisk kondenserte 1,4-dihydropyridiner, fremgangsmåte for fremstilling derav og deres anvendelse som legemidler | |
NO20001288D0 (no) | Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmÕte for fremstilling derav og anvendelse som legemiddel | |
NO20010219L (no) | Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel | |
NO974934D0 (no) | 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmåte for deres fremstilling og legemidler som inneholder disse forbindelsene | |
NO903978D0 (no) | Pyridinyl-kinolonforbindelser, deres fremstilling og bruk. | |
NO983472D0 (no) | Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene | |
DK0727416T3 (da) | Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som | |
NO903169D0 (no) | 4,1,2-1h-benzoksadiaziner og deres fremstilling. | |
NO960272L (no) | Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme | |
NO941517L (no) | 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse | |
DK0811593T3 (da) | 1,4-diaryl-2-flour-2-buten som insektcider og acaricider | |
DK1053224T3 (da) | Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel | |
EE04117B1 (et) | Karboksüasendatud tsüklilised karboksamiidi derivaadid, nende valmistamise meetod ja kasutamine | |
NO890096D0 (no) | Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter. | |
DK1157020T3 (da) | Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-oler, fremgangsmåder til deres fremstilling og deres anvendelse som lægemiddel | |
IT8919524A0 (it) | Derivati dal 1 arilsolfonil 2 piperidone, loro procedimento di preparazione e loro impiego come farmaci. | |
NO973486D0 (no) | Substituerte indanylidinacetylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikamenter eller diagnostikum og medikamenter inneholdende forbindelsene | |
DE68909873D1 (de) | 1,4-Dihydropyridin-Derivate. |